Aggressive prostate cancer: adjuvant therapy needed after surgery

Radical prostatectomy alone is no match for ultra-high radiation therapy, results show

Patients with the worst Gleason scores on diagnosis of prostate cancer who opt for surgery need adjuvant therapy if they are to optimise their chances of survival, a study suggests.

“Men with a Gleason score of 9 or 10 prostate cancer on biopsy comprise only a few percent of all prostate cancer diagnosed … worldwide, yet it is the vast majority of those who die of the disease,” said senior author, Dr Anthony D’Amico, a professor of radiation oncology at Harvard University, US.

The prospective study, which was not a randomised controlled trial, included 639 men with